The NCLT has admitted an insolvency plea against Evoq Remedies for failing to refund a ₹1.95 crore advance, marking the beginning of insolvency proceedings against the company.
NCLT Admits Section 9 IBC Plea Against Evoq Remedies
The NCLT has initiated insolvency proceedings against Evoq Remedies Limited, following the admission of a plea concerning a ₹1.95 crore advance paid for goods that were never delivered. The Tribunal ruled that the failure to refund the amount triggers insolvency actions under Section 9 of the IBC.
This ruling signifies stringent enforcement of creditor rights and the Tribunal's proactive role in addressing defaults in the supply chain, facilitating a swift response to claims that jeopardize creditor confidence.
Legal practitioners should be aware of the implications of this decision on similar supplier disputes, reinforcing the importance of adherence to contractual obligations and timely execution to avoid insolvency repercussions.
Citations
- NCLT Order (2026) 1 NCLT 6
